NovoCure reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of NovoCure using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-10-30 | $-0.28 | $-0.33 | 15.2 % |
Jun 2024 | 2024-07-25 | $-0.31 | $-0.41 | 24.4 % |
Mar 2024 | 2024-05-02 | $-0.36 | $-0.42 | 14.3 % |
Dec 2023 | 2024-02-22 | $-0.45 | $-0.52 | 13.5 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-10-30 | $155.10M | $143.95M | 7.74 % |
Jun 2024 | 2024-07-25 | $150.36M | $135.82M | 10.7 % |
Mar 2024 | 2024-05-02 | $138.50M | $131.45M | 5.37 % |
Dec 2023 | 2024-02-22 | $133.78M | $131.19M | 1.98 % |
NovoCure (NVCR) is scheduled to report earnings on February 20, 2025. The last reported earnings were for reported on October 30, 2024 for Q3.
The Actual EPS was $-0.28, which beat the estimate of $-0.33.
The Actual Revenue was $155.1M, which beat the estimate of $143.9M.
Browse earnings estimates, EPS, and revenue on all stocks.